KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Total Liabilities (2016 - 2026)

Abbott Laboratories' Total Liabilities history spans 18 years, with the latest figure at $57.7 billion for Q1 2026.

  • On a quarterly basis, Total Liabilities fell 29.62% to $57.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $57.7 billion, a 29.62% decrease, with the full-year FY2025 number at $34.6 billion, down 38.53% from a year prior.
  • Total Liabilities hit $57.7 billion in Q1 2026 for Abbott Laboratories, up from $34.6 billion in the prior quarter.
  • Over the last five years, Total Liabilities for ABT hit a ceiling of $82.9 billion in Q2 2022 and a floor of -$32.4 billion in Q4 2022.
  • Historically, Total Liabilities has averaged $54.4 billion across 5 years, with a median of $56.3 billion in 2024.
  • Biggest five-year swings in Total Liabilities: plummeted 88.12% in 2022 and later skyrocketed 249.33% in 2023.
  • Tracing ABT's Total Liabilities over 5 years: stood at -$32.4 billion in 2022, then skyrocketed by 249.33% to $48.3 billion in 2023, then rose by 16.37% to $56.3 billion in 2024, then crashed by 38.53% to $34.6 billion in 2025, then surged by 66.93% to $57.7 billion in 2026.
  • Business Quant data shows Total Liabilities for ABT at $57.7 billion in Q1 2026, $34.6 billion in Q4 2025, and $33.2 billion in Q3 2025.